Logo image of CLMT

CALUMET INC (CLMT) Stock Fundamental Analysis

NASDAQ:CLMT - Nasdaq - US1314281049 - Common Stock - Currency: USD

15.5  +0.03 (+0.19%)

After market: 15.5 0 (0%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to CLMT. CLMT was compared to 211 industry peers in the Oil, Gas & Consumable Fuels industry. CLMT may be in some trouble as it scores bad on both profitability and health. CLMT is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year CLMT has reported negative net income.
In the past year CLMT has reported a negative cash flow from operations.
In the past 5 years CLMT reported 4 times negative net income.
In multiple years CLMT reported negative operating cash flow during the last 5 years.
CLMT Yearly Net Income VS EBIT VS OCF VS FCFCLMT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M -400M

1.2 Ratios

CLMT has a Return On Assets of -10.83%. This is amonst the worse of the industry: CLMT underperforms 88.24% of its industry peers.
Looking at the Return On Invested Capital, with a value of 0.72%, CLMT is doing worse than 80.39% of the companies in the same industry.
Industry RankSector Rank
ROA -10.83%
ROE N/A
ROIC 0.72%
ROA(3y)-5.39%
ROA(5y)-5.31%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CLMT Yearly ROA, ROE, ROICCLMT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100 -100

1.3 Margins

CLMT has a worse Operating Margin (0.24%) than 82.35% of its industry peers.
CLMT's Operating Margin has improved in the last couple of years.
The Gross Margin of CLMT (4.74%) is worse than 79.41% of its industry peers.
CLMT's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 0.24%
PM (TTM) N/A
GM 4.74%
OM growth 3YN/A
OM growth 5Y13.91%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.26%
GM growth 5Y-2.85%
CLMT Yearly Profit, Operating, Gross MarginsCLMT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 10

More info and screens

0

2. Health

2.1 Basic Checks

CLMT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
There is no outstanding debt for CLMT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CLMT Yearly Shares OutstandingCLMT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
CLMT Yearly Total Debt VS Total AssetsCLMT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B 2.5B

2.2 Solvency

CLMT has an Altman-Z score of 0.88. This is a bad value and indicates that CLMT is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of CLMT (0.88) is worse than 61.27% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.88
ROIC/WACC0.07
WACC10.04%
CLMT Yearly LT Debt VS Equity VS FCFCLMT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M -500M 1B 1.5B

2.3 Liquidity

CLMT has a Current Ratio of 0.63. This is a bad value and indicates that CLMT is not financially healthy enough and could expect problems in meeting its short term obligations.
CLMT has a Current ratio of 0.63. This is amonst the worse of the industry: CLMT underperforms 82.84% of its industry peers.
CLMT has a Quick Ratio of 0.63. This is a bad value and indicates that CLMT is not financially healthy enough and could expect problems in meeting its short term obligations.
CLMT has a worse Quick ratio (0.30) than 93.63% of its industry peers.
Industry RankSector Rank
Current Ratio 0.63
Quick Ratio 0.3
CLMT Yearly Current Assets VS Current LiabilitesCLMT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

More info and screens

5

3. Growth

3.1 Past

The earnings per share for CLMT have decreased strongly by -630.77% in the last year.
Measured over the past years, CLMT shows a very strong growth in Earnings Per Share. The EPS has been growing by 67.45% on average per year.
The Revenue has grown by 24.23% in the past year. This is a very strong growth!
Measured over the past years, CLMT shows a small growth in Revenue. The Revenue has been growing by 3.63% on average per year.
EPS 1Y (TTM)-630.77%
EPS 3YN/A
EPS 5Y67.45%
EPS Q2Q%-193.65%
Revenue 1Y (TTM)24.23%
Revenue growth 3Y22.61%
Revenue growth 5Y3.63%
Sales Q2Q%-4.26%

3.2 Future

CLMT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 39.49% yearly.
The Revenue is expected to grow by 6.34% on average over the next years.
EPS Next Y-458.16%
EPS Next 2Y-43.1%
EPS Next 3Y9.73%
EPS Next 5Y39.49%
Revenue Next Year-1.16%
Revenue Next 2Y0.19%
Revenue Next 3Y-2.72%
Revenue Next 5Y6.34%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CLMT Yearly Revenue VS EstimatesCLMT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2B 4B 6B
CLMT Yearly EPS VS EstimatesCLMT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 2 -2 4 -4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CLMT. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CLMT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CLMT Price Earnings VS Forward Price EarningsCLMT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300 -400

4.2 Price Multiples

CLMT's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. CLMT is more expensive than 75.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 22.78
CLMT Per share dataCLMT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-43.1%
EPS Next 3Y9.73%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CLMT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CALUMET INC

NASDAQ:CLMT (2/20/2025, 8:07:40 PM)

After market: 15.5 0 (0%)

15.5

+0.03 (+0.19%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)11-08 2024-11-08/bmo
Earnings (Next)03-06 2025-03-06
Inst Owners27.34%
Inst Owner Change17.81%
Ins Owners3.85%
Ins Owner Change-0.6%
Market Cap1.33B
Analysts78.33
Price Target27.67 (78.52%)
Short Float %11.12%
Short Ratio6.39
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-20.46%
Min EPS beat(2)-55.7%
Max EPS beat(2)14.77%
EPS beat(4)2
Avg EPS beat(4)-16.15%
Min EPS beat(4)-55.7%
Max EPS beat(4)25.47%
EPS beat(8)4
Avg EPS beat(8)-659.22%
EPS beat(12)4
Avg EPS beat(12)-483.07%
EPS beat(16)6
Avg EPS beat(16)-330.41%
Revenue beat(2)2
Avg Revenue beat(2)12.12%
Min Revenue beat(2)10.98%
Max Revenue beat(2)13.26%
Revenue beat(4)4
Avg Revenue beat(4)9.27%
Min Revenue beat(4)3.37%
Max Revenue beat(4)13.26%
Revenue beat(8)7
Avg Revenue beat(8)8.38%
Revenue beat(12)11
Avg Revenue beat(12)11.76%
Revenue beat(16)15
Avg Revenue beat(16)12.2%
PT rev (1m)7.43%
PT rev (3m)6.37%
EPS NQ rev (1m)-25.43%
EPS NQ rev (3m)-3525%
EPS NY rev (1m)0.36%
EPS NY rev (3m)-38.56%
Revenue NQ rev (1m)-0.79%
Revenue NQ rev (3m)-10.54%
Revenue NY rev (1m)-0.1%
Revenue NY rev (3m)3.94%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.26
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 22.78
EPS(TTM)-2.76
EYN/A
EPS(NY)-0.04
Fwd EYN/A
FCF(TTM)-1.56
FCFYN/A
OCF(TTM)-0.59
OCFYN/A
SpS60.76
BVpS-7.82
TBVpS-7.82
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -10.83%
ROE N/A
ROCE 0.92%
ROIC 0.72%
ROICexc 0.74%
ROICexgc 0.74%
OM 0.24%
PM (TTM) N/A
GM 4.74%
FCFM N/A
ROA(3y)-5.39%
ROA(5y)-5.31%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y15.06%
ROICexc growth 3YN/A
ROICexc growth 5Y16.35%
OM growth 3YN/A
OM growth 5Y13.91%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.26%
GM growth 5Y-2.85%
F-Score2
Asset Turnover1.98
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 10.4
Cap/Depr 56.68%
Cap/Sales 1.59%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.63
Quick Ratio 0.3
Altman-Z 0.88
F-Score2
WACC10.04%
ROIC/WACC0.07
Cap/Depr(3y)269.2%
Cap/Depr(5y)179.87%
Cap/Sales(3y)6.86%
Cap/Sales(5y)4.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-630.77%
EPS 3YN/A
EPS 5Y67.45%
EPS Q2Q%-193.65%
EPS Next Y-458.16%
EPS Next 2Y-43.1%
EPS Next 3Y9.73%
EPS Next 5Y39.49%
Revenue 1Y (TTM)24.23%
Revenue growth 3Y22.61%
Revenue growth 5Y3.63%
Sales Q2Q%-4.26%
Revenue Next Year-1.16%
Revenue Next 2Y0.19%
Revenue Next 3Y-2.72%
Revenue Next 5Y6.34%
EBIT growth 1Y-94.99%
EBIT growth 3YN/A
EBIT growth 5Y18.05%
EBIT Next Year-42.55%
EBIT Next 3Y14.7%
EBIT Next 5Y20.12%
FCF growth 1Y53.62%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-136.97%
OCF growth 3YN/A
OCF growth 5YN/A